Avet Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVET
AVET has forty-one approved drugs.
Drugs and US Patents for Avet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 208923-001 | Nov 8, 2022 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Avet Lifesciences | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 202275-001 | Oct 31, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Avet Lifesciences | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 202061-001 | Jan 27, 2012 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

